Sessa Capital IM, L.P.'s Form 4 filing
Provention Bio, Inc. (PRVB) · filed Jan 20, 2023
- Accession no.
- 0001062993-23-001185
- Filed
- Jan 20, 2023, 4:10 PM ET
- Trade date
- Jan 18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $28.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sessa Capital IM, L.P.CIK 0001595849 | 10% Owner |
| Sessa Capital (Master), L.P.CIK 0001618360 | 10% Owner |
| Sessa Capital GP, LLCCIK 0001618699 | 10% Owner |
| Sessa Capital IM GP, LLCCIK 0001618700 | 10% Owner |
| Petry JohnCIK 0001618702 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Common Stock | SSaleDisposed | −3,000,000 | $9.40 | −$28,200,000 | 11,879,023 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.